OBJECTIVE: To examine the effect of breastfeeding during the postpartum oral glucose tolerance test (OGTT) on maternal blood glucose and insulin among women with recent gestational diabetes mellitus. METHODS: Participants were enrolled in the Study of Women, Infant Feeding, and Type 2 Diabetes, a prospective observational cohort study of 1,035 Kaiser Permanente Northern California members who had been diagnosed with GDM and subsequently underwent a 2-hour 75-g OGTT at 6-9 weeks postpartum for the study enrollment examinations from 2008 to 2011. For this analysis, we selected 835 study participants who reported any intensity of lactation and were observed either breastfeeding their infants (ie, putting the infant to the breast) or not breastfeeding during the OGTT. RESULTS: Of 835 lactating women, 205 (25%) breastfed their infants during the 2-hour 75-g OGTT at 6-9 weeks postpartum. Mean (standard deviation) duration of breastfeeding during the OGTT was 15.3 (8.1) minutes. Compared with not having breastfed during the OGTT, having breastfed during the test was associated with lower adjusted mean (95% confidence interval) 2-hour glucose (mg/dL) by -6.2 (-11.5 to -1.0; P=.02), 2-hour insulin (microunits/mL) by -15.1 (-26.8 to -3.5; P=.01), and natural log 2-hour insulin by -0.15 (-0.25 to -0.06; P<.01), and with higher insulin sensitivity index0,120 by 0.08 (0.02-0.15; P=.02), but no differences in plasma fasting glucose or insulin concentrations. CONCLUSION: Among postpartum women with recent gestational diabetes mellitus, breastfeeding an infant during the 2-hour 75-g OGTT may modestly lower plasma 2-hour glucose (5% lower on average) as well as insulin concentrations in response to ingestion of glucose.
OBJECTIVE: To examine the effect of breastfeeding during the postpartum oral glucose tolerance test (OGTT) on maternal blood glucose and insulin among women with recent gestational diabetes mellitus. METHODS:Participants were enrolled in the Study of Women, Infant Feeding, and Type 2 Diabetes, a prospective observational cohort study of 1,035 Kaiser Permanente Northern California members who had been diagnosed with GDM and subsequently underwent a 2-hour 75-g OGTT at 6-9 weeks postpartum for the study enrollment examinations from 2008 to 2011. For this analysis, we selected 835 study participants who reported any intensity of lactation and were observed either breastfeeding their infants (ie, putting the infant to the breast) or not breastfeeding during the OGTT. RESULTS: Of 835 lactating women, 205 (25%) breastfed their infants during the 2-hour 75-g OGTT at 6-9 weeks postpartum. Mean (standard deviation) duration of breastfeeding during the OGTT was 15.3 (8.1) minutes. Compared with not having breastfed during the OGTT, having breastfed during the test was associated with lower adjusted mean (95% confidence interval) 2-hour glucose (mg/dL) by -6.2 (-11.5 to -1.0; P=.02), 2-hour insulin (microunits/mL) by -15.1 (-26.8 to -3.5; P=.01), and natural log 2-hour insulin by -0.15 (-0.25 to -0.06; P<.01), and with higher insulin sensitivity index0,120 by 0.08 (0.02-0.15; P=.02), but no differences in plasma fasting glucose or insulin concentrations. CONCLUSION: Among postpartum women with recent gestational diabetes mellitus, breastfeeding an infant during the 2-hour 75-g OGTT may modestly lower plasma 2-hour glucose (5% lower on average) as well as insulin concentrations in response to ingestion of glucose.
Authors: Boyd E Metzger; Thomas A Buchanan; Donald R Coustan; Alberto de Leiva; David B Dunger; David R Hadden; Moshe Hod; John L Kitzmiller; Siri L Kjos; Jeremy N Oats; David J Pettitt; David A Sacks; Christos Zoupas Journal: Diabetes Care Date: 2007-07 Impact factor: 19.112
Authors: C J Hubinont; H Balasse; S P Dufrane; V Leclercq-Meyer; J Sugar; J Schwers; W J Malaisse Journal: Gynecol Obstet Invest Date: 1988 Impact factor: 2.031
Authors: Anthony J G Hanley; Ken Williams; Clicerio Gonzalez; Ralph B D'Agostino; Lynne E Wagenknecht; Michael P Stern; Steven M Haffner Journal: Diabetes Date: 2003-02 Impact factor: 9.461
Authors: Erica P Gunderson; Susana L Matias; Shanta R Hurston; Kathryn G Dewey; Assiamira Ferrara; Charles P Quesenberry; Joan C Lo; Barbara Sternfeld; Joseph V Selby Journal: BMC Public Health Date: 2011-12-23 Impact factor: 3.295
Authors: Maria A Ramos-Roman; Majid M Syed-Abdul; Beverley Adams-Huet; Brian M Casey; Elizabeth J Parks Journal: Diabetes Date: 2020-05-08 Impact factor: 9.461
Authors: Erica P Gunderson; Catherine Kim; Charles P Quesenberry; Santica Marcovina; David Walton; Robert A Azevedo; Gary Fox; Cathie Elmasian; Stephen Young; Nora Salvador; Michael Lum; Yvonne Crites; Joan C Lo; Xian Ning; Kathryn G Dewey Journal: Metabolism Date: 2014-04-13 Impact factor: 8.694
Authors: Duke Appiah; Cora E Lewis; David R Jacobs; James M Shikany; Charles P Quesenberry; Myron Gross; Jeff Carr; Stephen Sidney; Erica P Gunderson Journal: J Clin Endocrinol Metab Date: 2021-05-13 Impact factor: 5.958
Authors: Erica P Gunderson; Shanta R Hurston; Kathryn G Dewey; Myles S Faith; Nancy Charvat-Aguilar; Vicky C Khoury; Van T Nguyen; Charles P Quesenberry Journal: BMC Pregnancy Childbirth Date: 2015-07-17 Impact factor: 3.007